Zdv Use to Prevent Maternal/Infant HIV Transmission

Ruff, Andrea Jenay

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Research Project (R01)
• Project #: 5R01AI038576-02
• Application #: 2004350
• Study Section: AIDS and Related Research Study Section 2 (ARRB)
• Project Start: 1995-09-15
• Project End: 2000-08-31
• Budget Start: 1996-09-01
• Budget End: 1997-08-31
• Support Year: 2
• Fiscal Year: 1996

Institution

• Name: Johns Hopkins University
• Department: Public Health & Prev Medicine
• Type: Schools of Public Health
• DUNS #: 045911138
• City: Baltimore
• State: MD
• Country: United States
• Zip Code: 21218

Publications

Ziemniak, Carrie; Mengistu, Yohannes; Ruff, Andrea et al. (2011) Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings. J Clin Microbiol 49:4077-82

Persaud, Deborah; Bedri, Abubaker; Ziemniak, Carrie et al. (2011) Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission. AIDS Res Hum Retroviruses 27:823-9

Six Week Extended-Dose Nevirapine (SWEN) Study Team; Bedri, Abubaker; Gudetta, Berhanu et al. (2008) Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 372:300-13